Terminated NA INTERVENTIONAL 2-arm NCT04764396

Assessing Effects of Heparin Priming and Pass Number on Tissue Quality of Fine Needle Biopsies

Sponsor: University of Michigan

Interventions Heparin will be used for needle priming (BD PosiFlush™ Pre-Filled Heparin Lock Flush Syringe) Saline

Updated 6 times since 2021 Last updated: May 28, 2024 Started: Mar 12, 2021 Primary completion: Apr 6, 2021 Completion: Jul 6, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of funding and change in research direction.

Other terminated trials from University of Michigan

See all terminations from University of Michigan

This NA trial investigates Mass Lesion and Pancreas and is currently terminated or withdrawn. University of Michigan leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA

Status: Recruiting → Terminated
May 2023 — Jul 2024 [monthly]

Recruiting NA
May 2022 — May 2023 [monthly]

Recruiting NA
May 2021 — May 2022 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Mar 2021 — May 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Michigan

Data source: University of Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ann Arbor, United States